fda semaglutide shortage lawsuit 📢 has determined the of injection products, a glucagon-like peptide 1 (GLP-1) medication, is resolved. Patients and prescribers may still see intermittent and limited localized supply disruptions as the Wegovy® Lawsuit | July 2026

also approved for chronic weight management in adults (refer to current MHRA and NICE Technology Appraisal guidance for the applicable indication and eligibility criteria) [4] [7] Orlistat available on NHS prescription and over the counter Naltrexone/bupropion (Mysimba) available in some settings, though NHS commissioning varies by region [10] NICE Technology Appraisals provide eligibility criteria and commissioning guidance for semaglutide and tirzepatide in weight management

Potassium supplementation above food-derived amounts should involve medical supervision

There are other downsides: Versions of semaglutide have been on the market for several years, but the long-term effects of taking drugs that override human metabolism are not yet clear

For a researcher, that means you can order it without a prescription as a research-use-only product